Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian CancerZsofia Sztupinszki, Miklos Diossy, Judit Borcsok, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2023
Safety and management of niraparib monotherapy in ovarian cancer clinical trialsBradley J Monk, Antonio González-Martin, Lynn Buckley, et al.BMC Cancer|February 7, 2014
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)Kristina Lindemann, Susanne Malander, Rene D Christensen, et al.Future Oncology (London, England)|July 6, 2022
Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic contextAntonio González-Martín, Ursula A Matulonis, Jacob Korach, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, et al.Basic & Clinical Pharmacology & Toxicology|September 30, 2011
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancerTroels K Bergmann, Charlotte Brasch-Andersen, Henrik Gréen, et al.European Journal of Clinical Pharmacology|February 18, 2011
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancerTroels K Bergmann, Henrik Gréen, Charlotte Brasch-Andersen, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2010
The value of gynecologic cancer follow-up: evidence-based ignorance?Henrik Lajer, Mette B Jensen, Jannie Kilsmark, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinomaJonathan A Ledermann, Daniela Luvero, Aaron Shafer, et al.Pageof 5